Comparing original vs. AI-made plain language summaries
Part of Cancer, Skin clinical trials.
This trial tests if an AI-generated plain language summary is as good as a human-written one for women with breast cancer. It compares how patients understand information about their treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with non-metastatic breast cancer (cancer that hasn't spread beyond the breast or nearby lymph nodes).
- You are currently getting chemotherapy or radiation therapy as part of your treatment.
- You are receiving one of these treatments: chemotherapy before surgery (neoadjuvant), after surgery (adjuvant), or radiation after surgery (adjuvant).
- You can read and understand Croatian.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether simplified, easy-to-read versions of your hospital discharge letters help you better understand your diagnosis and treatment plan. Researchers will ask you questions about the letter to see if the plain-language version works better than the standard medical version.
This study tests new AI-created summaries of cancer imaging reports (like CT or MRI scans) that are written in plain language to help you better understand your results. Researchers want to see if these summaries help cancer patients and their doctors communicate more clearly about imaging findings.
This trial uses a computer program (large language model) to help doctors read Chinese PSMA PET/CT reports. The goal is to see if the AI can accurately identify key details about prostate cancer, like where it has spread, which may help make staging and treatment decisions faster.
This trial compares treatment recommendations from large language models (AI) against those from experienced tumor boards for five common cancer types. The goal is to see if AI can help doctors make better decisions.
This trial uses a special PET/MRI scan combined with artificial intelligence to see if it can predict whether HER2-positive breast cancer will completely disappear after treatment given before surgery. The goal is to learn who might avoid surgery or get a more tailored approach.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
Hear when a new Non-metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.